FilingReader Intelligence
MedPlus subsidiary faces drug license suspension
August 15, 2025 at 01:39 PM UTC•By FilingReader AI
MedPlus Health Services announced its subsidiary Optival Health Solutions Private Limited received a four-day drug license suspension for a store in Telangana. The August 14 order cites contraventions under the Drugs and Cosmetics Act, resulting in potential revenue loss of approximately Rs0.80 lacs.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:MEDPLUS•Bombay Stock Exchange
News Alerts
Get instant email alerts when Medplus Health Services publishes news
Free account required • Unsubscribe anytime